Yang Zhao

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 6

Top Topics

Chronic Kidney Disease

Signaling Pathway

Top Venues

Drug design, development and therapy

Investigative and clinical urology

This page only lists publications with an associated author ORCID identifier.

Publications

Yang Zhao, Yi-Han Wang, Wei-Chao Tu, Da-Wei Wang, Mu-Jun Lu, Yuan Shao
Costunolide Inhibits Chronic Kidney Disease Development by Attenuating IKKβ/NF-κB Pathway. Drug design, development and therapy 18 (2024)
Yang Zhao, Yi-Han Wang, Wei-Chao Tu, Da-Wei Wang, Mu-Jun Lu, Yuan Shao
Costunolide Inhibits Chronic Kidney Disease Development by Attenuating IKKβ/NF-κB Pathway. Drug design, development and therapy 18 (2024)
Baoxing Huang, Guoliang Lu, Yang Zhao, Weichao Tu, Yuan Shao, Dawei Wang, Dan-Feng Xu
The mean Hounsfield unit range acquired from different slices produces superior predictive accuracy for pyonephrosis in obstructive uropathy. Investigative and clinical urology 65 (3) (2024)
Baoxing Huang, Guoliang Lu, Yang Zhao, Weichao Tu, Yuan Shao, Dawei Wang, Dan-Feng Xu
The mean Hounsfield unit range acquired from different slices produces superior predictive accuracy for pyonephrosis in obstructive uropathy. Investigative and clinical urology 65 (3) (2024)
Yang Zhao, Yi-Han Wang, Wei-Chao Tu, Da-Wei Wang, Mu-Jun Lu, Yuan Shao
Costunolide Inhibits Chronic Kidney Disease Development by Attenuating IKKβ/NF-κB Pathway. Drug design, development and therapy 18 (2024)
Baoxing Huang, Guoliang Lu, Yang Zhao, Weichao Tu, Yuan Shao, Dawei Wang, Dan-Feng Xu
The mean Hounsfield unit range acquired from different slices produces superior predictive accuracy for pyonephrosis in obstructive uropathy. Investigative and clinical urology 65 (3) (2024)